Absci's AI-Powered Drug Hunt: Unpacking the Potential of ABS-101 and ABS-201

Legend Biotech's Carvykti: A Beacon of Hope Reshaping Multiple Myeloma Treatment

A Beacon of Hope: BPGbio's BPM31510 Earns FDA Orphan Drug Status for Primary CoQ10 Deficiency

Corvus Pharmaceuticals Takes Key Step Forward with Lead Eczema Drug

A Glimpse into Tomorrow: Kelun Biotech Unveils Bold Vision at J.P. Morgan Healthcare Conference

The Unseen Engine of Medicine: Small Molecule API Market Poised for Explosive Growth

Amgen's Horizon: Bradway Shares Strategic Vision with Cramer

More Than Business: Incyte's Identity Forged in the Blood Cancer Battle

Unlocking New Frontiers: How Revolution Medicines and Merck Are Redefining the Cancer Fight

ArriVent BioPharma: Decoding the 'Cautious Buy' on Furmonertinib

Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

Unpacking the Data: InflaRx's Continued Deep Dive into Vilobelimab for Pyoderma Gangrenosum

InflaRx's Vilobelimab: A Deeper Look into Pyoderma Gangrenosum Trial Data

The Dawn of AI-Driven Cures: Insilico Medicine's Historic Hong Kong Debut

A New Horizon for Essential Tremor: Praxis's Ulixacaltamide Earns Breakthrough Status

The Biotech Buzz: Is Abivax Poised to Be the Next Big Acquisition?

A Game-Changer for Assembly Bio: Gilead's Nod Sends Stock Soaring

Terns Pharmaceuticals Soars: A New Dawn for Tough-to-Treat Leukemia Patients?

Incyte Unveils Game-Changing Myelofibrosis Data at ASH 2025

ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders

A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting

The Bittersweet Breakthrough: Gertrude Elion's Pioneering Drug in the Fight Against Childhood Leukemia

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The Unyielding Riddle of Alzheimer's: Why Progress Feels So Elusive

Malaria's Hidden Strategy: Unmasking the Parasite's Corkscrew Journey Through Our Skin

Cassava Sciences' Simufilam Trial Faces Fresh FDA Scrutiny

The Enduring Quest: Semaglutide and the Unyielding Challenge of Alzheimer's

Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?

Regeneron and Tessera Forge Potent Alliance for Next-Generation Gene Editing Therapies

The Looming Shadow: Why Our New Plan to Fight Antimicrobial Resistance Needs a Serious Boost

A New Chapter in Rare Disease Treatment: Omeros and Novo Nordisk Finalize Landmark Zaltenibart Deal

A Beacon of Hope: Reviva Pharmaceuticals' Brilaroxazine Achieves Pivotal Milestones in Schizophrenia Treatment

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M

A New Era for Drug Safety: DiPharma Francis Publishes Groundbreaking Nitrosamine Detection Study

The Shifting Tides: Is Animal Testing Nearing Its End?

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance